Core Viewpoint - The company has approved a profit distribution plan at the fourth extraordinary general meeting of shareholders on November 14, 2025, which includes a cash dividend distribution for the first three quarters of 2025 [1]. Distribution Plan - The distribution is based on a total share capital of 573,886,283 shares, with 20,961,800 shares in the company's repurchase account excluded, resulting in a base of 552,924,483 shares for the cash dividend distribution of 0.14 yuan per 10 shares (including tax), totaling 7,740,942.76 yuan (including tax) [2]. - The cash dividend per share is calculated to be approximately 0.0135 yuan after adjusting for the total share capital [2][4]. - The company will only distribute cash dividends without issuing new shares or capital reserve transfers, meaning there will be no change in the circulating shares [2]. Relevant Dates - The cash dividend distribution will be executed through the China Securities Depository and Clearing Corporation Limited Shanghai Branch, with shareholders able to receive their dividends on the designated payment date [5]. Taxation Information - For individual shareholders holding unrestricted circulating shares, the tax treatment varies based on the holding period, with a maximum tax rate of 20% for shares held for one month or less, and a reduced rate of 10% for shares held between one month and one year [6]. - For Qualified Foreign Institutional Investors (QFII), a 10% corporate income tax will be withheld, resulting in a net cash dividend of 0.0126 yuan per share [7]. - Other institutional investors are responsible for their own tax obligations, with a cash dividend of 0.014 yuan per share [7].
河南太龙药业股份有限公司 2025年前三季度权益分派实施公告